- GALE has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $17.0 million.
- GALE has traded 1.4 million shares today.
- GALE is up 3.6% today.
- GALE was down 7.6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in GALE with the Ticky from Trade-Ideas. See the FREE profile for GALE NOW at Trade-Ideas More details on GALE: Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. Currently there are 4 analysts that rate Galena Biopharma a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Galena Biopharma has been 3.4 million shares per day over the past 30 days. Galena has a market cap of $362.2 million and is part of the health care sector and drugs industry. The stock has a beta of 0.78 and a short float of 10.7% with 2.17 days to cover. Shares are up 48.3% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.